Atara biotherapeutics names cell therapy & oncology leader cokey nguyen, ph.d. as chief scientific officer

South san francisco, calif.--(business wire)--atara biotherapeutics, inc. (nasdaq: atra), a pioneer in t-cell immunotherapy, leveraging its novel allogeneic ebv t-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease, today named cell therapy and oncology expert cokey nguyen, ph.d. as chief scientific officer. “with his passion for serving patients and a deep commitment to delivering results, we're
ATRA Ratings Summary
ATRA Quant Ranking